Showing 4721-4730 of 5771 results for "".
- Lineage Cell Therapeutics Reports New Data With OpRegen for the Treatment of Dry AMD With Geographic Atrophyhttps://modernod.com/news/lineage-cell-therapeutics-reports-new-data-with-opregen-for-the-treatment-of-dry-amd-with-geographic-atrophy/2477713/Lineage Cell Therapeutics announced that updated results from a phase 1/2a study of its lead product candidate OpRegen, a retinal pigment epithelium (RPE) cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD), were published online via th
- AbbVie, Allergan Gain US Antitrust Clearance for Dealhttps://modernod.com/news/abbvie-allergan-gain-us-antitrust-clearance-for-deal/2477714/The US Federal Trade Commission (FTC) accepted the proposed consent order in connection with AbbVie’s pending $63-billion acquisition of Allergan, the companies announced. The FTC’s decision means that all required antitrust clearances needed for the merger have now been obtained.
- Massachusetts Eye and Ear Advancing Experimental Gene-Based COVID-19 Vaccine, AAVCOVIDhttps://modernod.com/news/massachusetts-eye-and-ear-advancing-experimental-gene-based-covid-19-vaccine-aavcovid/2477708/Massachusetts Eye and Ear and Massachusetts General Hospital (MGH), members of Mass General Brigham, announced progress toward the testing and development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. The
- Icare USA New Confocal Fundus Imaging System and Handheld Tonometerhttps://modernod.com/news/icare-usa-new-confocal-fundus-imaging-system-and-handheld-tonometer/2477707/Icare USA announced the release of two new diagnostic technologies: the Centervue DRSplus confocal fundus imaging system, and the Icare ic200 handheld tonometer for portable measurement of IOP. “We’re excited to introduce clinicians to these new technologies—the disruptive DRSplus platform
- Adverum Biotechnologies Reports Positive Interim Data of ADVM-022 Intravitreal Gene Therapy for Wet AMDhttps://modernod.com/news/adverum-biotechnologies-reports-positive-interim-data-of-advm-022-intravitreal-gene-therapy-for-wet-amd/2477705/Adverum Biotechnologies announced new interim clinical data from Cohorts 1-3 of the OPTIC phase 1 dose-ranging clinical trial of ADVM-022 intravitreal (IVT) injection gene therapy in patients requiring frequent anti-VEGF injections for their wet age-related macular degeneration (AMD) and provided
- Alnylam, Vir to Advance Experimental RNAi Therapeutic VIR-2703 as Potential COVID-19 Treatmenthttps://modernod.com/news/alnylam-vir-to-advance-experimental-rnai-therapeutic-vir-2703-as-potential-covid-19-treatment/2477702/Alnylam Pharmaceuticals and Vir Biotechnology announced that they plan to develop VIR-2703, an investigational RNAi therapeutic targeting the SARS-CoV-2 genome as an inhalational formulation for the potential treatment or prevention of COVID-19. “To our knowledge, this is one of the
- NIH Mobilizes National Innovation Initiative For COVID-19 Diagnosticshttps://modernod.com/news/nih-mobilizes-national-innovation-initiative-for-covid-19-diagnostics/2477698/The National Institutes of Health (NIH) announced a new initiative aimed at speeding innovation, development, and commercialization of COVID-19 testing technologies. With a $1.5 billion investment from federal stimulus funding, the newly launched Rapid Acceleration of Diagnostics (RADx) in
- Kala Pharmaceuticals Resubmits NDA for Eysuvis for Dry Eye Diseasehttps://modernod.com/news/kala-pharmaceuticals-resubmits-nda-for-eysuvis-for-dry-eye-disease/2477696/Kala Pharmaceuticals announced that it has resubmitted its new drug application (NDA) to the FDA for Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25%, a product candidate for the short-term treatment of the signs and symptoms of dry eye disease. Kala believes this application will be c
- CheckedUp Launches Virtual Visits Telehealth Platform for Specialty Carehttps://modernod.com/news/checkedup-launches-virtual-visits-telehealth-platform-for-specialty-care/2477689/CheckedUp announced the launch of CheckedUp Virtual Visits, a telemedicine system designed to improve virtual specialty care. CheckedUp Virtual Visits was created to keep patients and physicians at the center of pivotal health care decisions as “point of care” engagement evolves with pa
- ELT Sight’s ExTra Excimer Laser Trabeculostomy Procedure Receives New CPT Codeshttps://modernod.com/news/elt-sights-extra-excimer-laser-trabeculostomy-procedure-receives-new-cpt-codes/2477680/ELT Sight announced that the American Medical Association (AMA) approved two new Category III Current Procedural Terminology (CPT) codes to report ELT Sight’s ExTra Excimer Laser Trabeculostomy (ELT) procedure. The two new codes, to be used for reporting trabeculostomy ab interno by laser with or